Cinven Pays $915M For Clinical Research Co. Medpace

Law360, New York (February 24, 2014, 12:16 PM EST) -- European private equity firm Cinven shelled out $915 million to pick up clinical research company Medpace Inc. from New York-based buyout firm CCMP Capital Advisors LLC, Cinven said Monday, highlighting a growing interest in the clinical research organization industry. 

Under the terms of the transaction, Cinven will also hand over certain cash inflows relating to CCMP's period of ownership, the firm said. The transaction is subject to regulatory approval before completion.

Medpace helps plan and oversee clinical trials for the research and development departments of pharmaceutical, biotech...
To view the full article, register now.